Atherosclerosis
Volume 195, Issue 1 , Pages e191-e196 , November 2007

Sex differences in the relation of HDL cholesterol to progression of carotid intima-media thickness: The Los Angeles Atherosclerosis Study

  • Amy Z. Fan

      Affiliations

    • Corresponding Author InformationCorresponding author at: 4770 Buford Hwy NE, MS K-47, Atlanta, GA 30341, United States. Tel.: +1 770 488 5327; fax: +1 770 488 8334.
    • ,
  • James H. Dwyer

      Affiliations

    • Deceased.

Received 27 December 2006 ,Revised 3 March 2007 ,Accepted 27 March 2007.

References 

  1. Maron DJ. The epidemiology of low levels of high-density lipoprotein cholesterol in patients with and without coronary artery disease. Am J Cardiol. 2000;86:11–14
  2. Simons LA, McCallum J, Friedlander Y, Simons J. Risk factors for ischemic stroke: Dubbo Study of the elderly. Stroke. 1998;29:1341–1346
  3. Baldassarre D, Amato M, Pustina L, et al. Increased carotid artery intima-media thickness in subjects with primary hypoalphalipoproteinemia. Arterioscler Thromb Vasc Biol. 2002;22:317–322
  4. Plump AS, Scott CJ, Breslow JL. Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse. Proc Natl Acad Sci USA. 1994;91:9607–9611
  5. Navab M, Berliner JA, Subbanagounder G, et al. HDL and the inflammatory response induced by LDL-derived oxidized phospholipids. Arterioscler Thromb Vasc Biol. 2001;21:481–488
  6. Serfaty-Lacrosniere C, Civeira F, Lanzberg A, et al. Homozygous tangier disease and cardiovascular disease. Atherosclerosis. 1994;107:85–98
  7. Goldbourt U, Medalie JH. High density lipoprotein cholesterol and incidence of coronary heart disease—the Israeli Ischemic Heart Disease Study. Am J Epidemiol. 1979;109:296–308
  8. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med. 1977;62:707–714
  9. Women's health initiative, risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA 2002;288:321–33.
  10. O’Leary DH, Polak JF, Kronmal RA, et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med. 1999;340:14–22
  11. Sun P, Dwyer KM, Merz CN, et al. Blood pressure, LDL cholesterol, and intima-media thickness: a test of the “response to injury” hypothesis of atherosclerosis. Arterioscler Thromb Vasc Biol. 2000;20:2005–2010
  12. Dwyer JH, Sun P, Kwong-Fu H, Dwyer KM, Selzer RH. Automated intima-media thickness: the Los Angeles Atherosclerosis Study. Ultrasound Med Biol. 1998;24:981–987
  13. Kakuyama T, Kimura S, Hashiguchi Y. Fully automated determination of HDL-cholesterol from human serum with Hitachi 911 [Abstract]. Clin Chem. 1994;40:1104
  14. DeLong DM, DeLong ER, Wood PD, Lippel K, Rifkind BM. A comparison of methods for the estimation of plasma low- and very low-density lipoprotein cholesterol. The Lipid Research Clinics Prevalence Study. JAMA. 1986;256:2372–2377
  15. Dwyer JH, Feinleib M. Introduction to statistical models for longitudinal observation. In:  Dwyer JH, et al. editor. Statistical models for longitudinal studies of health. New York: Oxford University; 1992;p. 1–48
  16. Boden WE. High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the veterans affairs high-density lipoprotein intervention trial. Am J Cardiol. 2000;86:19L–22L
  17. Rubins HB, Robins SJ, Collins D, et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans affairs high-density lipoprotein cholesterol intervention trial study group. N Engl J Med. 1999;341:410–418
  18. NCEP, Executive summary of the third report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001;285:2486–97.
  19. Barbaras R, Puchois P, Fruchart JC, Ailhaud G. Cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI:AII particles. Biochem Biophys Res Commun. 1987;142:63–69
  20. Duverger N, Rader D, Duchateau P, et al. Biochemical characterization of the three major subclasses of lipoprotein A-I preparatively isolated from human plasma. Biochemistry. 1993;32:12372–12379
  21. Fruchart JC, Ailhaud G. Apolipoprotein A-containing lipoprotein particles: physiological role, quantification, and clinical significance. Clin Chem. 1992;38:793–797
  22. Warden CH, Hedrick CC, Qiao JH, Castellani LW, Lusis AJ. Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II. Science. 1993;261:469–472
  23. Navab M, Hama-Levy S, Van Lenten BJ, et al. Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio. J Clin Invest. 1997;99:2005–2019
  24. Zhong S, Sharp DS, Grove JS, et al. Increased coronary heart disease in Japanese–American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest. 1996;97:2917–2923
  25. Berard AM, Foger B, Remaley A, et al. High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithin-cholesteryl acyltransferase. Nat Med. 1997;3:744–749
  26. Kakko S, Tamminen M, Paivansalo M, et al. Variation at the cholesteryl ester transfer protein gene in relation to plasma high density lipoproteins cholesterol levels and carotid intima-media thickness. Eur J Clin Invest. 2001;31:593–602
  27. Nofer JR, Kehrel B, Fobker M, et al. HDL and arteriosclerosis: beyond reverse cholesterol transport. Atherosclerosis. 2002;161:1–16
  28. Kashyap ML. Basic considerations in the reversal of atherosclerosis: significance of high-density lipoprotein in stimulating reverse cholesterol transport. Am J Cardiol. 1989;63:56H–59H
  29. Dwyer KM, Nordstrom CK, Bairey Merz CN, Dwyer JH. Carotid wall thickness and years since bilateral oophorectomy: the Los Angeles Atherosclerosis Study. Am J Epidemiol. 2002;156:438–444
  30. Karim R, Mack WJ, Lobo RA, et al. Determinants of the effect of estrogen on the progression of subclinical atherosclerosis: estrogen in the prevention of atherosclerosis trial. Menopause. 2005;12:366–373
  31. Fan AZ, Paul-Labrador M, Merz CN, Iribarren C, Dwyer JH. Smoking status and common carotid artery intima-medial thickness among middle-aged men and women based on ultrasound measurement: a cohort study. BMC Cardiovasc Disord. 2006;6:42

PII: S0021-9150(07)00209-2

doi: 10.1016/j.atherosclerosis.2007.03.045

Atherosclerosis
Volume 195, Issue 1 , Pages e191-e196 , November 2007

Article Tools

* Image Usage & Resolution